Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

Clinical antimicrobial susceptibility breakpoints are used to predict the clinical outcome of antimicrobial treatment. In contrast, microbiologic breakpoints are used to identify isolates that may be categorized as susceptible when applying clinical breakpoints but harbor resistance mechanisms that...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sue Lim, Darrin Bast, Allison McGeer, Joyce de Azavedo, Donald E. Low
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Centers for Disease Control and Prevention 2003-07-01
coleção:	Emerging Infectious Diseases
Assuntos:	fluoroquinolone resistance levofloxacin resistance antimicrobial susceptibility testing topoisomerase research Canada
Acesso em linha:	https://wwwnc.cdc.gov/eid/article/9/7/02-0589_article
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!